Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,629 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00854282 | The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression(Tregs) | unknown | N/A | 50 | National Taiwan University HospitalOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00854399 | Screening and Identification of Ovarian Cancers | unknown | N/A | 250 | National Taiwan University HospitalOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00596349 | Women Surviving Ovarian Cancer | completed | — | 62 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00726635 | The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies | unknown | Phase 3 | 60 | Rabin Medical CenterOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00204633 | Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) | completed | Phase 2 | 108 | University Hospital TuebingenOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00113789 | Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer | completed | Phase 2 | 21 | AmgenINDUSTRY | 0 | Feb 13, 2009 | clinicaltrials |
| NCT00003977 | Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer | completed | Phase 1 | — | Steward St. Elizabeth's Medical Center of Boston, Inc.OTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00354471 | Uterine Artery Embolization for Symptomatic Fibroids | completed | — | — | University of ManitobaOTHER | 1 | Feb 5, 2009 | clinicaltrials |
| NCT00156026 | Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 | completed | Phase 3 | 415 | Ontario Clinical Oncology Group (OCOG)OTHER | 2 | Jan 29, 2009 | clinicaltrials |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | completed | Phase 1 | 15 | SCRI Development Innovations, LLCOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00826891 | Study of Cisplatin in Cervical Cancer Stage IVB | unknown | Phase 2 | 40 | Chinese Anti-Cancer AssociationOTHER | 0 | Jan 22, 2009 | clinicaltrials |
| NCT00374114 | A Pilot Study to Evaluate Ultrasonic Surgical Aspiration as a Treatment Modality for Cervical Dysplasia | completed | N/A | 20 | University of TennesseeOTHER | 1 | Dec 15, 2008 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00400348 | Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer | completed | Phase 2 | 18 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00753480 | A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | suspended | Phase 1 | 56 | Genentech, Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00772798 | A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer | unknown | Phase 2 | 70 | Herlev HospitalOTHER | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00069901 | Phase II CT-2103/Carboplatin in Ovarian Cancer | completed | Phase 2 | 82 | CTI BioPharmaINDUSTRY | 1 | Sep 22, 2008 | clinicaltrials |
| NCT00159328 | Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids | completed | Phase 4 | 50 | Imperial College LondonOTHER | 1 | Aug 13, 2008 | clinicaltrials |
| NCT00526370 | Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests | completed | — | 72 | University of AarhusOTHER | 1 | Aug 13, 2008 | clinicaltrials |
| NCT00728871 | The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis | unknown | N/A | 600 | National Taiwan University HospitalOTHER | 1 | Aug 6, 2008 | clinicaltrials |
| NCT00075543 | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00674349 | Screening of Biomarkers on Endometrial Cancers | unknown | N/A | 250 | National Taiwan University HospitalOTHER | 1 | Jul 22, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00715286 | Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study | unknown | Phase 3 | 180 | All India Institute of Medical SciencesOTHER | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00299481 | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease | unknown | — | 7,000 | U.S. Army Medical Research and Development CommandFED | 1 | Jun 30, 2008 | clinicaltrials |
| NCT00391664 | Questionnaire Study for Gynecological Cancer Survivors | unknown | — | 1,000 | U.S. Army Medical Research and Development CommandFED | 1 | Jun 30, 2008 | clinicaltrials |
| NCT00451945 | New Indications for Ultrasound in the Staging of Cervical Cancer | withdrawn | N/A | — | Rigshospitalet, DenmarkOTHER | 1 | Jun 18, 2008 | clinicaltrials |
| NCT00173290 | Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00150644 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | completed | Phase 2 | 33 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00152256 | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | completed | Phase 3 | 239 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156208 | Safety of Treatment of Uterine Fibroids With Asoprisnil | completed | Phase 3 | 166 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156156 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | completed | Phase 3 | 149 | AbbottINDUSTRY | 0 | May 28, 2008 | clinicaltrials |
| NCT00548821 | Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer | unknown | Phase 3 | — | National University Hospital, SingaporeOTHER | 1 | May 15, 2008 | clinicaltrials |
| NCT00493545 | Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia | unknown | Phase 1 | 24 | Nventa Biopharmaceuticals CorporationINDUSTRY | 1 | May 7, 2008 | clinicaltrials |
| NCT00673192 | Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | May 7, 2008 | clinicaltrials |
| NCT00436189 | Assess Cancer in Ovarian Tumors With Biomarkers. | completed | N/A | 1,000 | Ciphergen BiosystemsINDUSTRY | 1 | Apr 30, 2008 | clinicaltrials |
| NCT00655447 | Examining the Long-Term Risks of Oophorectomy | completed | — | 32,175 | Parker, William H., M.D.OTHER | 1 | Apr 9, 2008 | clinicaltrials |
| NCT00377845 | Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear. | completed | Early Phase 1 | 100 | University of AarhusOTHER | 1 | Mar 27, 2008 | clinicaltrials |
| NCT00001272 | A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001302 | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001427 | A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001468 | Outcomes of Education and Counseling for BRCA1 Testing | completed | — | 1,500 | National Human Genome Research Institute (NHGRI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00006155 | SU5416 and Carboplatin to Treat Ovarian Cancer | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00090389 | Acupuncture for Women's Health Conditions | completed | Phase 1 | 50 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00087841 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | completed | Phase 2 | 390 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00591656 | Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer | unknown | — | 69 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00592059 | Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer | unknown | — | 77 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Mar 3, 2009source: clinicaltrials